Skip to search formSkip to main contentSkip to account menu

Rapacuronium bromide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Review
2002
Review
2002
Rapacuronium is an aminosteroidal nondepolarising neuromuscular blocking agent (NMBA). Its neuromuscular blocking effects have a… 
Review
2001
Review
2001
The pharmacodynamics and pharmacokinetics of the two most recent aminosteroid neuromuscular blocking drugs to become available… 
2001
2001
Patients receiving anticonvulsants such as phenytoin or carbamazepine may be resistant to neuromuscular blocking agents. The… 
1999
1999
BACKGROUND Nondepolarizing muscle relaxants differ in their time course at the laryngeal adductors and the adductor pollicis, a… 
Review
1999
Review
1999
UNLABELLED Rapacuronium bromide (rapacuronium) is an aminosteroid, nondepolarising neuromuscular blocking agent (NMBA). At the… 
Review
1999
Review
1999
Rapacuronium is a new steroidal, nondepolarizing, neuromuscular blocking agent. It appears to be the least potent of all… 
1999
1999
  • A. N. Plowman
  • 1999
  • Corpus ID: 34131988
Organon Teknika's rapacuronium bromide (Org-9487), the 16-N-allyl, 17-beta-propionate analog of vecuronium bromide, is in phase…